Senior insider sale
Chief Executive Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$790.3K
50.22K shares
What this filing means
BARROW ROBERT plans to sell 50.22K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $790.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/25/2026ACC: 0001950047-26-003007
DirectorOfficer· Chief Executive Officer
Since Jan 2022
50.22K
Shares to sell
$790.3K
Approx. market value
24.43K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Services Rendered
3/25/2026
24.43KTotal acquired24.43K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/25/2026 | Restricted stock vesting under a registered plan Services Rendered | 24.43K | — |
| Total | 24.43K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
25.79K
Market value
$339.1K
12/26/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
24.43K
Market value
$451.2K
3/25/2026
Total
Units
50.22K
Value
$790.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/26/2025 | 25.79K | $339.1K | — | Completed |
| Planned — Approximate Date | ||||
3/25/2026 | 24.43K | $451.2K | NASDAQ | Planned |
| Total | 50.22K | $790.3K | ||